MyndTec Inc. Bolsters Growth with Non-Brokered Private Placement

MyndTec Inc. (CSE: MYTC), a medical technology company specializing in neurological treatment and rehabilitation, has announced a non-brokered private placement offering of up to 533,333 units at a price of $0.75 per unit. The offering aims to raise aggregate gross proceeds of up to $480,000, which the company plans to use for general corporate purposes, including working capital, corporate development, and sales and marketing.

The private placement is an important step for MyndTec, as it allows the company to raise capital without the need for a broker, reducing fees and maintaining control over the process. The offering is open to investors in Canada, the United States, and other jurisdictions where available prospectus or registration exemptions apply.

MyndTec's focus on neurostimulation technologies, such as the MyndMove system, positions the company at the forefront of innovative treatments for individuals suffering from diseases, disorders, and damage to the central nervous system. The private placement will enable MyndTec to continue its research and development efforts, invest in new opportunities, and expand its reach.

The company's long-term growth strategy and investment philosophy emphasize steady performers and a balanced portfolio. The private placement aligns with this approach by providing MyndTec with the resources it needs to maintain its operations, invest in new opportunities, and execute strategic acquisitions.

In conclusion, MyndTec's non-brokered private placement is a significant step towards strengthening the company's financial stability and supporting its long-term growth strategy. By raising capital through this offering, MyndTec can continue to invest in its core operations, research and development, and strategic acquisitions, ultimately driving the company's success in the neurological treatment and rehabilitation market.